Journal
ORGANOGENESIS
Volume 7, Issue 1, Pages 28-31Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/org.7.1.14027
Keywords
VWF; ADAMTS-13; thrombocytopenia-associated multiple organ failure (TAMOF); plasma exchange; TTP; DIC; thrombotic microangiopathy
Funding
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM083212] Funding Source: NIH RePORTER
- NIGMS NIH HHS [K08 GM083212] Funding Source: Medline
Ask authors/readers for more resources
Thrombotic microangiopathies (TMAs) are syndromes associated with thrombocytopenia and multiple organ failure. Plasma exchange is a proven therapy for primary TMA, such as thrombotic thrombocytopenic purpura (TTP). There is growing evidence that plasma exchange therapy might also facilitate resolution of organ dysfunction and improve outcomes for secondary TMAs, such as disseminated intravascular coagulation (DIC) and systemic inflammation-induced TTP. In this review, we survey the current available evidence and practice of plasma exchange therapy for TMAs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available